One-time gene therapy reverses liver disease MASH in mouse models

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than 40 million people. The results were obtained with a single intramuscular administration of the therapeutic viral vectors.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup